TWO SIGMA INVESTMENTS, LP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$130,176
-53.2%
90,400
-12.9%
0.00%
-100.0%
Q1 2023$278,138
-87.3%
103,783
-74.3%
0.00%
-85.7%
Q4 2022$2,189,935
-33.1%
403,303
+53.8%
0.01%
-36.4%
Q3 2022$3,275,000
+492.2%
262,182
+134.2%
0.01%
+450.0%
Q2 2022$553,000
+203.8%
111,932
+368.6%
0.00%
+100.0%
Q1 2022$182,000
-86.9%
23,885
-82.5%
0.00%
-66.7%
Q4 2021$1,391,000
+22.3%
136,235
+60.8%
0.00%0.0%
Q3 2021$1,137,000
-91.7%
84,731
-86.5%
0.00%
-90.3%
Q2 2021$13,729,000
-31.8%
625,754
-25.3%
0.03%
-40.4%
Q1 2021$20,145,000
+296.4%
837,276
+196.4%
0.05%
+246.7%
Q4 2020$5,082,000
+169.5%
282,475
+73.0%
0.02%
+114.3%
Q3 2020$1,886,000
+41.4%
163,310
+34.9%
0.01%
-36.4%
Q1 2020$1,334,000
-24.5%
121,049
+81.0%
0.01%
+120.0%
Q4 2019$1,767,000
+582.2%
66,871
+487.6%
0.01%
+400.0%
Q3 2019$259,000
-87.9%
11,380
-91.2%
0.00%
-85.7%
Q1 2019$2,148,000
+47.8%
129,420
+70.6%
0.01%
+16.7%
Q4 2018$1,453,000
-7.3%
75,857
+79.3%
0.01%
+20.0%
Q1 2018$1,567,000
+217.8%
42,305
+70.1%
0.01%
+150.0%
Q4 2017$493,00024,8730.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
MPM BioImpact LLC 856,798$6,512,0001.75%
CHI Advisors LLC 488,635$3,714,0001.58%
Pinz Capital Management, LP 186,515$1,418,0000.88%
Lombard Odier Asset Management (Switzerland) SA 542,183$4,121,0000.32%
Rhenman & Partners Asset Management AB 316,137$2,403,0000.24%
Birchview Capital, LP 40,000$304,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 160,000$1,216,0000.18%
Tekla Capital Management LLC 423,869$3,221,0000.11%
Golden Green, Inc. 12,152$92,0000.08%
Virtus ETF Advisers LLC 15,188$115,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders